| 1 |
Rauf, Abdul, Sumayya Qazi, Bashir Ahmad Malik, Sehar Aslam, Urooj Anwar, Usman Ali Ashfaq, and Rashid Bhatti. |
Novel Phytochemical Inhibitors of Leptin: A Molecular Docking Approach for Potential Cardiovascular and Antidiabetic Therapies |
Journal of Liaquat University of Medical & Health Sciences |
155-162 |
2025 |
24 |
0
|
|
| 2 |
Afaq Akram, Fatima Noor, Abdur Rehman, Nida Khalid, Muhammad Tahir Ul Qamar, Rana Alateeq, Naimah Ibrahim Aldhulayfi, Abdulmajeed A. A. Sindi, and Usman Ali Ashfaq. |
Deciphering the Role of Honey in Ocular Diseases by Integrating Network Pharmacology and Molecular Modeling Approaches for Retinal Therapy |
Computational Biophysics and Chemistry |
1-14 |
2025 |
25 |
2.3
|
|
| 3 |
Tayyab Ijaz, Hamna Maqsood, Abdur Rehman, Muhammad Tahir ul Qamar & Usman Ali Ashfaq |
Explainable machine learning identifies immune-inflammatory biomarkers and therapeutic candidates in drug-resistant epilepsy |
Scientific Reports |
965 |
2025 |
16 |
3.9
|
|
| 4 |
Rabia Akbar, Iqra Muneer, Usman Ali Ashfaq, Muhammad Rizwan Javed, Rana Alateeq, Nahlah Makki Almansour, Ahmad Almatroudi, Faris Alrumaihi, Khaled S. Allemailem, and Muhammad Tahir ul Qamar |
Discovery of Phytochemical Inhibitors Targeting HPV E6 Oncoprotein Using Integrative Machine Learning and Molecular Modeling for Cervical Cancer Therapy |
Computational Biophysics and Chemistry |
1-15 |
2025 |
25 |
2.3
|
|
| 5 |
Hadi, Fazal, Fatima Noor, Haseeba Sardar, Hany W. Darwish, Usman Ali Ashfaq, Ashraf Ali Khan, Maria Daglia, and Haroon Khan |
Integrating In Vitro, Network Pharmacology, and Molecular Docking Approaches to Uncover the Antidiabetic Potential of Tylophora hirsuta |
Computational Biology and Chemistry |
108533 |
2025 |
119 |
3.1
|
|
| 6 |
Sajjad, Muhammad Waseem, Fatima Muzamil, Maida Sabir, and Usman Ali Ashfaq |
Regenerative Medicine and Nanotechnology Approaches against Cardiovascular Diseases: Recent Advances and Future Prospective |
Current Stem Cell Research & Therapy |
50-71 |
2025 |
20 |
2.2
|
|
| 7 |
Bibi, Fatima, Abdul Rauf, Mohsin Ahmad Khan, Usman Ali Ashfaq, Muhammad Qasim Awan, Muhammad Shareef Masoud, Rabia Zarmeena, Munir Ahmed Bhinder, Muhammad Hamza Afandi, and Rashid Bhatti. |
Network Pharmacological Study of Papaver Somniferum to Explore the Potential Compounds to Treat Epilepsy |
Journal of Liaquat University of Medical & Health Sciences |
25-32 |
2025 |
24 |
0
|
|
| 8 |
Shokat, Zeeshan, Farhat Ibraheem, Arina Akmal, Matloob Ahmad, Muhammad Sufyan, Mariam Naveed, Bushra Ijaz, Sana Aslam, and Usman Ali Ashfaq |
Design, Synthesis, In vitro, Molecular Docking and Simulation Assessment of Benzimidazole Derivatives Against Liver Cancer by Targeting STAT3, Bcl2 and MDM2 |
Journal of Computational Biophysics and Chemistry |
1-33 |
2025 |
12 |
2.3
|
|
| 9 |
Shokat, Zeeshan, Muhammad Sufyan, Abdulrahman Alshammari, Norah A. Albekairi, Thamer H. Albekairi, Mohsin Khurshid, Umair Waqas, and Usman Ali Ashfaq |
Integrative Network Pharmacology to Evaluate Bioactive Phytochemicals of Aesculus hippocastanum and Their Multitarget Mechanisms Against Chronic Venous Insufficiency |
Scientifica |
6871086 |
2025 |
1 |
3.1
|
|
| 10 |
Hayat, Muhammad, Nosheen Aslam, Usman Ali Ashfaq, and Muhammad Afzal |
Single nucleotide polymorphism analysis of LPL gene and its impact in fibrate therapy in hypertriglyceridemic patients |
Pakistan journal of Pharmaceutical Sciences |
1-12 |
2025 |
38 |
.6
|
|
| 11 |
Asma Khalil, Fatima Noor, Muhammad Tahir ul Qamar, Sadia Liaqat, Nazia Nahid, Asma Haque & Usman Ali Ashfaq |
Identification and computational analysis of conserved YXX?? motifs in the pan-serotypes of dengue virus NS5 protein and their implications in host-virus interactions |
Journal of Biomolecular Structure and Dynamics |
2204-2217 |
2025 |
44 |
2.4
|
|
| 12 |
QASIM M, ABDULLAH M, ASHFAQ UA, NOOR F, NAHID N, ALZAMAMI A, ALTURKI NA, KHURSHID M |
Molecular mechanism of Ferula asafoetida for the treatment of asthma: Network pharmacology and molecular docking approach |
Saudi Journal of Biological Sciences |
103527 |
2023 |
30 |
4.052
|
|
| 13 |
N FATIMA, MSU RAHMAN, M QASIM, UA ASHFAQ, U AHMED, MS MASOUD |
Transcriptional Factors mediated Reprogramming to Pluripotency |
Current stem cell research and therapy |
1 |
2023 |
18 |
3.828
|
|
| 14 |
F NOOR, M ASIF, UA ASHFAQ, M QASIM, M TAHIR UL QAMAR |
Machine learning for synergistic network pharmacology: a comprehensive overview |
Briefings in Bioinformatics |
1-27 |
2023 |
24 |
13.99
|
|
| 15 |
KAMAL I, ASHFAQ UA, HAYAT S, ASLAM B, SARFRAZ MH, YASEEN H, RAJOKA MS, SHAH AA, KHURSHID M |
Prospects of antimicrobial peptides as an alternative to chemical preservatives for food safety |
Biotechnology Letters |
137?162 |
2023 |
45 |
2.672
|
|
| 16 |
UAA S MEHDI, MH MEHMOOD, MG AHMED, UA ASHFAQ |
Antidiabetic activity of Berberis brandisiana is possibly mediated through modulation of insulin signaling pathway, inflammatory cytokines and adipocytokines in high fat diet and streptozotocin-administered rats |
Frontiers in Pharmacology |
1085013 |
2023 |
14 |
5.988
|
|
| 17 |
NOOR F, UA ASHFAQ, BAKAR A, UL HAQ W, ALLEMAILEM KS, ALHARBI BF, AL-MEGRIN WAI, UL QAMAR MT |
Discovering common pathogenic processes between COVID-19 and HFRS by integrating RNA-Seq differential expression analysis with machine learning |
Frontiers in Microbiology |
1-12 |
2023 |
14 |
6.064
|
|
| 18 |
B AHMAD, UA ASHFAQ, MS MASOUD, N NAHID, M TARIQ, M QASIM |
E-nose-based technology for healthcare |
Nanotechnology-Based E-noses |
241-256 |
2023 |
1 |
0
|
|
| 19 |
I ANWAR, UA ASHFAQ |
Impact of nanotechnology on differentiation and augmentation of stem cells for liver therapy |
Critical Reviews TM in Therapeutic Drug Carrier Systems |
1 |
2023 |
40 |
4.681
|
|
| 20 |
L ZARA, R HUSSAIN, MS MASOUD, N NASEEM, HU AHMAD, UA ASHFAQ, KHALIQ S |
Dysregulation of gene expression of PTEN and AKT signaling pathway in patients of ovarian cancer: A pilot study |
Journal of King Saud University-Science |
102378 |
2023 |
35 |
3.829
|
|
| 21 |
NOOR F, REHMAN A, ASHFAQ UA, SALEEM MH, OKLA MK, AL-HASHIMI A, ABDELGAWAD H, ASLAM S |
Integrating Network Pharmacology and Molecular Docking Approaches to Decipher the Multi-Target Pharmacological Mechanism of Abrus precatorius L. Acting on Diabetes |
Pharmaceuticals |
414 |
2022 |
15 |
5.215
|
|
| 22 |
S MUNIR, M KHURSHID, M AHMAD, UA ASHFAQ, MEA ZAKI |
Exploring the Antimicrobial and Pharmacological Potential of NF22 as a Potent Inhibitor of E. coli DNA Gyrase: An In Vitro and In Silico Study |
Pharmaceutics 14 (12), |
2768 |
2022 |
14 |
6.525
|
|
| 23 |
RASHID F, JAVAID A, ASHFAQ UA, SUFYAN M, ALSHAMMARI A, ALHARBI M, NISAR MA, KHURSHID M |
Integrating Pharmacological and Computational Approaches for the Phytochemical Analysis of Syzygium cumini and Its Anti-Diabetic Potential |
Molecules |
5734 |
2022 |
27 |
4.927
|
|
| 24 |
F NOOR, UA ASHFAQ, M ASIF, M MUZAMMAL ADEEL, A ALSHAMMARI, M ALHARBI |
Comprehensive computational analysis reveals YXX?[I/L/M/F/V] motif and YXX?-like tetrapeptides across HFRS causing Hantaviruses and their association with viral pathogenesis and host immune regulation |
Frontiers in Immunology |
1031608 |
2022 |
13 |
8.786
|
|
| 25 |
SARFRAZ MH, SHAHID A, ASGHAR S, ASLAM B, ASHFAQ UA, RAZA H, PRIETO MA, SIMAL-GANDARA J, BARBA FJ, RAJOKA MSR, KHURSHID M, NASHWAN AJ |
Personalized nutrition, microbiota, and metabolism: A triad for eudaimonia |
Frontiers in Molecular Biosciences |
1038830 |
2022 |
9 |
6.113
|
|
| 26 |
A REHMAN, UA ASHFAQ, MR JAVED, F SHAHID, F NOOR, S ASLAM |
The Screening of phytochemicals against NS5 Polymerase to treat Zika Virus infection: Integrated computational based approach |
Combinatorial Chemistry and High Throughput Screening |
738-751 |
2022 |
25 |
1.707
|
|
| 27 |
FATIMA I, AHMAD S, ABBASI SW, ASHFAQ UA, SHAHID F, TAHIR UL QAMAR M, REHMAN A, ALLEMAILEM KS |
Designing of a multi-epitopes-based peptide vaccine against rift valley fever virus and its validation through integrated computational approaches |
Computers in Biology and Medicine |
105151 |
2022 |
141 |
6.698
|
|
| 28 |
F RASHID, M AHMAD, UA ASHFAQ, AA AL-MUTAIRI, SA AL-HUSSAIN |
Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1, 1-Dioxido-2H-Benzo [e][1, 2] thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent |
Drug Design, Development and Therapy |
4043-4060 |
2022 |
16 |
4.319
|
|
| 29 |
S TAJ, M AHMAD, UA ASHFAQ |
Exploring of novel 4-hydroxy-2H-benzo[e][1,2]thiazine-3-carbohydrazide 1,1-dioxide derivative as a dual inhibitor of ?-glucosidase and ?-amylase: Molecular docking, biochemical, enzyme kinetic and in-vivo mouse model study |
International Journal of Biological Macromolecules |
507-521 |
2022 |
207 |
8.025
|
|
| 30 |
ALAMRI MA, MIRZA MU, ADEEL MM, ASHFAQ UA, TAHIR UL QAMAR M, SHAHID F, AHMAD S, ALATAWI EA, ALBALAWI GM, ALLEMAILEM KS, ALMATROUDI A |
Structural elucidation of rift valley fever virus L protein towards the discovery of its potential inhibitors |
Pharmaceuticals |
659 |
2022 |
15 |
5.215
|
|
| 31 |
NOOR F, SALEEM MH, JAVED MR, CHEN JT, ASHFAQ UA, OKLA MK, ABDEL-MAKSOUD MA, ALWASEL YA, AL-QAHTANI WH, ALSHAYA H, YASIN G |
Comprehensive computational analysis reveals H5N1 influenza virus-encoded miRNAs and host-specific targets associated with antiviral immune responses and protein binding |
PloS ONE |
e0263901 |
2022 |
17 |
3.752
|
|
| 32 |
FA SADDIQUE, M AHMAD, UA ASHFAQ, M MUDDASSAR, S SULTAN, MEA ZAKI |
Identification of cyclic sulfonamides with an N-arylacetamide group as ?-glucosidase and ?-amylase inhibitors: Biological evaluation and molecular modeling |
Pharmaceuticals |
106 |
2022 |
15 |
5.215
|
|
| 33 |
TABASSUM S, KHALID HR, HAQ WU, ASLAM S, ALSHAMMARI A, ALHARBI M, RIAZ RAJOKA MS, KHURSHID M, ASHFAQ UA |
Implementation of System Pharmacology and Molecular Docking Approaches to Explore Active Compounds and Mechanism of Ocimum Sanctum against Tuberculosis |
Processes |
298 |
2022 |
10 |
3.352
|
|
| 34 |
KHALID H, KHALID S, SUFYAN M, ASHFAQ UA |
In-silico elucidation reveals potential phytochemicals against angiotensin-converting enzyme 2 (ACE-2) receptor to fight coronavirus disease 2019 (COVID-19) |
Zeitschrift fur Naturforschung C |
1-10 |
2022 |
77 |
1.885
|
|
| 35 |
KANWAL A, AZEEM F, NADEEM H, ASHFAQ UA, AADIL RM, KOBER AKMH, RAJOKA MSR, RASUL I |
Molecular Mechanisms of Cassia fistula against Epithelial Ovarian Cancer Using Network Pharmacology and Molecular Docking Approaches |
Pharmaceutics |
1970 |
2022 |
14 |
6.525
|
|
| 36 |
S TAJ, M AHMAD, A ALSHAMMARI, A ALGHAMDI, UA ASHFAQ |
Exploring the therapeutic potential of benzothiazine-pyrazole hybrid molecules against alpha-glucosidase: Pharmacological and molecular modelling based approach |
Saudi Journal of Biological Sciences |
14 |
2022 |
29 |
4.052
|
|
| 37 |
KHAN IA, SADDIQUE FA, ASLAM S, ASHFAQ UA, AHMAD M, AL-HUSSAIN SA, ZAKI ME |
Synthesis of Novel N-Methylmorpholine-Substituted Benzimidazolium Salts as Potential ?-Glucosidase Inhibitors |
Molecules |
6012 |
2022 |
27 |
4.927
|
|
| 38 |
H KHALID, UA ASHFAQ |
Molecular Docking and Pharmacoinformatics Studies Reveal Potential Phytochemicals Against HCV NS5B Polymerase |
Combinatorial Chemistry and High Throughput Screening |
335-346 |
2022 |
25 |
1.714
|
|
| 39 |
F NOOR, M TAHIR UL QAMAR, UA ASHFAQ, A ALBUTTI, ASS ALWASHMI, MA ALJASIR |
Network pharmacology approach for medicinal plants: Review and assessment |
Pharmaceuticals |
572 |
2022 |
15 |
5.215
|
|
| 40 |
HR KHALID, M AAMIR, S TABASSUM, YS ALGHAMDI, A ALZAMAMI, UA ASHFAQ |
Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of Solanum surattense against Hepatocellular Carcinoma |
Molecules |
6220 |
2022 |
27 |
4.927
|
|
| 41 |
GB KHAN, M QASIM, A RASUL, UA ASHFAQ, AM ALNUQAYDAN |
Identification of Lignan Compounds as New 6-Phosphogluconate Dehydrogenase Inhibitors for Lung Cancer |
Metabolites |
34 |
2022 |
13 |
5.581
|
|
| 42 |
ASLAM S, ASHFAQ UA, ZIA T, ASLAM N, ALRUMAIHI F, SHAHID F, NOOR F, QASIM M |
Proteome based mapping and reverse vaccinology techniques to contrive multi-epitope based subunit vaccine (MEBSV) against Streptococcus pyogenes |
Infection, Genetics and Evolution |
105259 |
2022 |
100 |
4.393
|
|
| 43 |
A JAVAID, A IJAZ, UA ASHFAQ, M ARSHAD, S IRSHAD, S SAIF |
An overview of chikungunya virus molecular biology, epidemiology, pathogenesis, treatment and prevention strategies |
Future Virology |
593-606 |
2022 |
17 |
3.015
|
|
| 44 |
S REHMAN, U ALI ASHFAQ, M SUFYAN, I SHAHID, B IJAZ, M HUSSAIN |
The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer?s disease targeting acetylcholinesterase |
PloS ONE |
e0264074 |
2022 |
17 |
3.752
|
|
| 45 |
F SHAHID, YS ALGHAMDI, M MASHRAQI, M KHURSHID, UA ASHFAQ |
Proteome based mapping and molecular docking revealed DnaA as a potential drug target against Shigella sonnei |
Saudi Journal of Biological Sciences |
1147-1159 |
2022 |
29 |
4.052
|
|
| 46 |
MANAN A, ASHFAQ UA, ANSARI MR |
Advancements in Wheat Research |
Wheat - Recent Advances. |
342 |
2022 |
1 |
0
|
|
| 47 |
AHMED U, ASHFAQ UA, QASIM M, U-RAHMAN M, KHALIQ S, TARIQ M, BHATTI R, MASOUD MS |
The Fate of Toxicological Studies: From Animal Models to Stem Cell-based Methods |
Frontiers in Stem Cell and Regenerative Medicine Research, Bentham Science Publishers |
103-122 |
2022 |
10 |
0
|
|
| 48 |
ASHFAQ UA, SHAHID F, MUNIR S |
Computational approaches for drug-metabolizing enzymes: Concepts and challenges, |
Biochemistry of Drug Metabolizing Enzymes,Academic Press, |
29-72 |
2022 |
1 |
0
|
|
| 49 |
SHAHID A, HAYAT S, MUNIR S, ASHFAQ UA, KHAN AA, BILAL M, SHAUKAT I, KHURSHID M |
Modulation of human microbiome and drug metabolism |
Biochemistry of Drug Metabolizing Enzymes, Academic Press |
375-397 |
2022 |
1 |
0
|
|
| 50 |
SUFYAN M, ALI ASHFAQ U, AHMAD S, NOOR F, HAMZAH SALEEM M, FARHAN ASLAM M, EL-SEREHY HA, ASLAM S |
Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis |
Saudi Journal of Biological Sciences |
5518-5525 |
2021 |
28 |
4.052
|
|
| 51 |
MHMOOD I, BARI A, AHMAD S, NAZ A, SHAHID F, ASHFAQ UA, TASLEEM K, QAMAR MT |
Immunoinformatics and its Role in Vaccine Development |
Frontiers in Molecular Pharming, Bentham Science Publishers |
30-65 |
2021 |
2 |
0
|
|
| 52 |
M SUFYAN, F SHAHID, F IRSHAD, A JAVAID, M QASIM, UA ASHFAQ |
Implementation of vaccinomics and in-silico approaches to construct multimeric based vaccine against ovarian cancer |
International Journal of Peptide Research and Therapeutics |
2845-2859 |
2021 |
27 |
2.028
|
|
| 53 |
SMH M RIZWAN, N ASLAM, UA ASHFAQ, M HAYAT |
SNP of HMGCR and Apo E genes and their impact in response to statin therapy in hypercholesterolemic and hypertriglyceridemic patients in Pakistan |
Pakistan journal of Pharmaceutical sciences |
1577-1583 |
2021 |
34 |
.863
|
|
| 54 |
TARIQ MH, BHATTI R, ALI NF, ASHFAQ UA, SHAHID F, ALMATROUDI A, KHURSHID M |
Rational design of chimeric Multiepitope Based Vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach |
PloS ONE |
e0258443 |
2021 |
16 |
3.752
|
|
| 55 |
ALDAKHEEL FM, ABRAR A, MUNIR S, ASLAM S, ALLEMAILEM KS, KHURSHID M, ASHFAQ UA |
Proteome-Wide Mapping and Reverse Vaccinology Approaches to Design a Multi-Epitope Vaccine against Clostridium perfringens |
Vaccines |
1079 |
2021 |
9 |
4.961
|
|
| 56 |
SA IMTIAZ, S SAEED, S MUNIR, UA ASHFAQ |
Subtractive proteomics to identify targets for vaccine development against vancomycin-resistant Enterococcus faecalis |
Future Microbiology |
1723-1733 |
2021 |
15 |
3.553
|
|
| 57 |
M MAHMOOD, A JAVAID, F SHAHID, UA ASHFAQ |
Rational design of multimeric based subunit vaccine against Mycoplasma pneumonia: Subtractive proteomics with immunoinformatics framework |
Infection, Genetics and Evolution |
104795 |
2021 |
91 |
4.393
|
|
| 58 |
H KHALID, S SHAHID, S TARIQ, B IJAZ, UA ASHFAQ, M AHMAD |
Discovery of Novel HCV NS5B polymerase inhibitor, 2-(3,4-dimethyl-5,5-dioxidobenzo[e]pyrazolo[4,3-c][1,2]thiazin-2(4H)-yl)-N-(2-fluorobenzyl)acetamide via molecular docking and experimental approach |
Clinical and Experimental Pharmacology and Physiology |
1653-1661 |
2021 |
48 |
2.963
|
|
| 59 |
SS K WALAYAT, M AHMAD, UA ASHFAQ, ZA KHAN |
Synthesis and a-glucosidase inhibition studies of norfloxacin-acetanilide hybrids |
Pakistan journal of Pharmaceutical sciences |
1909-1915 |
2021 |
34 |
.863
|
|
| 60 |
NOOR F, ASHFAQ UA, JAVED MR, SALEEM MH, AHMAD A, ASLAM MF, ASLAM S |
Comprehensive computational analysis reveals human respiratory syncytial virus encoded microRNA and host specific target genes associated with antiviral immune responses and protein binding |
Journal of King Saud University-Science |
101562 |
2021 |
33 |
3.829
|
|
| 61 |
IA KHAN, M AHMAD, UA ASHFAQ, S SULTAN, MEA ZAKI |
Discovery of Amide-Functionalized Benzimidazolium Salts as Potent ?-Glucosidase Inhibitors |
Molecules |
4760 |
2021 |
26 |
4.927
|
|
| 62 |
K BRICE LANDRY, S TARIQ, A MALIK, M SUFYAN, UA ASHFAQ, B IJAZ, AA SHAHID |
Berberis lyceum and Fumaria indica: in vitro cytotoxicity, antioxidant activity, and in silico screening of their selected phytochemicals as novel hepatitis C virus nonstructural protein 5A inhibitors |
Journal of Biomolecular Structure and Dynamics |
7829-7851 |
2021 |
40 |
5.235
|
|
| 63 |
KAUSAR N, HAQUE A, MASOUD MS, NAHID N, ASHFAQ UA, WARYAH AM, BHATTI R, QASIM M |
Disease-associated variants of Gap Junction Beta 2 protein (GJB2) in the deaf population of Southern Punjab of Pakistan |
PLoS ONE |
e0259083 |
2021 |
16 |
3.752
|
|
| 64 |
AHMED U, KHALIQ S, AHMAD HU, AHMAD I, ASHFAQ UA, QASIM M, MASOUD MS |
Pathogenesis of Diabetic Cardiomyopathy and role of miRNA |
Critical Reviews TM in Eukaryotic Gene Expression |
79-92 |
2021 |
31 |
2.333
|
|
| 65 |
SADDIQUE FA, ASLAM S, AHMAD M, ASHFAQ UA, MUDDASSAR M, SULTAN S, TAJ S, HUSSAIN M, SUNG LEE D, ZAKI MEA |
Synthesis and ?-Glucosidase Inhibition Activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl]-N-arylacetamides: An In Silico and Biochemical Approach |
Molecules |
3043 |
2021 |
26 |
4.927
|
|
| 66 |
AHMED U, AHMED R, MASOUD MS, TARIQ M, ASHFAQ UA, AUGUSTINE R, HASAN A |
Stem cells based in vitro models: trends and prospects in biomaterials cytotoxicity studies |
Biomedical Materials |
042003 |
2021 |
16 |
4.103
|
|
| 67 |
UMAR A, HAQUE A, ALGHAMDI YS, MASHRAQI MM, REHMAN A, SHAHID F, KHURSHID M, ASHFAQ UA |
Development of a candidate multi-epitope subunit vaccine against Klebsiella aerogenes: subtractive proteomics and immuno-informatics approach |
Vaccines |
1373 |
2021 |
9 |
4.961
|
|
| 68 |
ASHFAQ UA, SALEEM S, MASOUD MS, AHMAD M, NAHID N, BHATTI R, ALMATROUDI A, KHURSHID M |
Rational design of multi epitope-based subunit vaccine by exploring MERS-COV proteome: Reverse vaccinology and molecular docking approach |
PLoS ONE |
1e0245072 |
2021 |
16 |
3.752
|
|
| 69 |
JAVAID A, AKBAR I, JAVED H, KHAN U, IFTIKHAR H, ZAHRA D, RASHID F, ASHFAQ UA |
Role of heavy metals in Diabetes: Mechanism insight and treatment Strategies |
Critical Reviews TM in Eukaryotic Gene Expression |
65?80 |
2021 |
31 |
2.333
|
|
| 70 |
TAHIR UL QAMAR M, AHMAD S, FATIMA I, AHMAD F, SHAHID F, NAZ A, ABBASI SW, KHAN A, MIRZA MU, ASHFAQ UA, CHEN LL. |
Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches |
Computers in Biology and Medicine |
104389 |
2021 |
132 |
6.698
|
|
| 71 |
TAHIR UL QAMAR M, ISMAIL S, AHMAD S, MIRZA MU, ABBASI SW, ASHFAQ UA, CHEN LL |
Development of a novel multi-epitope vaccine against crimean-congo hemorrhagic fever virus: An integrated reverse vaccinology, vaccine informatics and biophysics approach |
Frontiers in Immunology |
669812 |
2021 |
12 |
8.786
|
|
| 72 |
H SALEEM, UA ASHFAQ, H NADEEM, M ZUBAIR, MH SIDDIQUE, I RASUL |
Subtractive genomics and molecular docking approach to identify drug targets against Stenotrophomonas maltophilia |
PloS ONE |
e0261111 |
2021 |
16 |
3.752
|
|
| 73 |
A JAVAID, D ZAHRA, A ASIM, N JAVAID, UA ASHFAQ |
Recent updates on the role of nanoparticles in the treatment of viral diseases |
Critical Reviews TM in Therapeutic Drug Carrier Systems |
75-102 |
2021 |
38 |
4.681
|
|
| 74 |
ASLAM S, AHMAD S, NOOR F, ASHFAQ UA, SHAHID F, REHMAN A, TAHIR UL QAMAR M, ALATAWI EA, ALSHABRMI FM, ALLEMAILEM KS |
Designing a Multi-Epitope Vaccine against Chlamydia trachomatis by Employing Integrated Core Proteomics, Immuno-Informatics and In Silico Approaches |
Biology |
997 |
2021 |
10 |
5.168
|
|
| 75 |
REHMAN A, AHMAD S, SHAHID F, ALBUTTI A, ALWASHMI ASS, ALJASIR MA, ALHUMEED N, QASIM M, ASHFAQ UA, TAHIR UL QAMAR M |
Integrated core proteomics, subtractive proteomics, and immunoinformatics investigation to unveil a potential multi-epitope vaccine against schistosomiasis |
Vaccines |
658 |
2021 |
9 |
4.961
|
|
| 76 |
AHMED U, ASHFAQ UA, QASIM M, AHMAD I, AHMAD HU, TARIQ M, MASOUD MS, KHALIQ S |
Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy |
PLoS One |
e0250773 |
2021 |
16 |
3.752
|
|
| 77 |
D ZAHRA, A JAVAID, M IQBAL, I AKBAR, UA ASHFAQ |
Synthesis and therapeutic potential of nanoceria against cancer: An update |
Critical Reviews TM in Therapeutic Drug Carrier Systems |
1-26 |
2021 |
38 |
4.681
|
|
| 78 |
A JAVAID, UA ASHFAQ, Z ZAFAR, A AKMAL, S TAJ, H KHALID |
Phytochemical analysis and antidiabetic potential of armoracia rusticana: Pharmacological and computational approach |
Combinatorial Chemistry and High Throughput Screening |
465-471 |
2021 |
24 |
1.339
|
|
| 79 |
AHMAD S, TAJ S, ASLAM S, GUL KHAN S, FAROOQ T, ASHFAQ UA, AHMAD M. |
In-silico modeling and in-vitro studies of 2,1-benzothiazine-2,2-dioxide based hydrazone derivatives as ?-glucosidase inhibitors. |
Pakistan Journal of Pharmaceutical Sciences |
1951-1955 |
2021 |
34 |
.863
|
|
| 80 |
ASLAM S, MUNIR S, MASOUD MS, ASHFAQ UA, NAHID N, KHURSHID M, QASIM M |
roteins and Peptides as Biomarkers for Diagnosis of Cardiovascular Diseases. |
Frontiers in Molecular Pharming, Bentham Science Publisher |
296-320 |
2021 |
1 |
0
|
|
| 81 |
FA SADDIQUE, M AHMAD, UA ASHFAQ, A ASLAM, SG KHAN |
Alpha-glucosidase inhibition and molecular docking studies of 4-hydroxy-N?-[benzylidene/1-phenylethylidene]-2H-1, 2-benzothiazine-3-carbohydrazide 1, 1-dioxides |
Chiang Mai Journal Of Science |
460-469 |
2021 |
48 |
.507
|
|
| 82 |
KHALID H, ASHFAQ UA |
Exploring HCV genome to construct multi-epitope based subunit vaccine to battle HCV infection: Immunoinformatics based approach |
Journal of Biomedical Informatics |
103498 |
2020 |
108 |
8
|
|
| 83 |
ASHFAQ UA, ZEESHAN, ANWAR I, IJAZ A, RASHEED A, MASOUD MS |
Microbe-based Antiangiogenesis Therapies for Cancer Management. |
Anti-Angiogenesis Drug Discovery and Development, Bentham Science Publishers |
86-124 |
2020 |
5 |
0
|
|
| 84 |
ANWAR I, ASHFAQ UA, SHOKAT Z. |
Therapeutic Potential of Umbilical Cord Stem Cells for Liver Regeneration |
Current Stem Cell Research & Therapy. |
219-232. |
2020 |
15 |
3.828
|
|
| 85 |
JAVAID A, ASHFAQ UA*, ZAFAR Z, AKMAL A, TAJ S, KHALID H. |
Phytochemical Analysis and Antidiabetic Potential of Armoracia Rusticana: Pharmacological and Computational Approach. |
Combinatorial Chemistry and High Throughput Screening |
465-471 |
2020 |
24 |
1.339
|
|
| 86 |
KHURSHID M, RASOOL MH, ASHFAQ UA, ASLAM B, WASEEM M, XU Q, ZHANG X, GUO Q, WANG M. |
Dissemination of blaOXA-23-harbouring carbapenem-resistant Acinetobacter baumannii clones in Pakistan. |
Journal of Global Antimicrobial Resistance |
357-362 |
2020 |
21 |
4.035
|
|
| 87 |
AHMED U, ASHFAQ UA*, KHALIQ S, QASIM M, JAHAN S. MASOUD MS. |
Current trends and possible therapeutic options against COVID-19. |
Journal of Microbiology and Infectious Diseases |
110-120 |
2020 |
10 |
2.837
|
|
| 88 |
ASHFAQ UA*, KHALID H. |
CRISPR/CAS9-Mediated Antiviral Activity: A Tool to Combat Viral Infection |
Critical Reviews? in Eukaryotic Gene Expression |
45-56. |
2020 |
30 |
1.807
|
|
| 89 |
SHAHID, F. ASHFAQ, U.A*. SAEED, S. MUNIR, S.; ALMATROUDI, A. KHURSHID, M. |
In-Silico Subtractive Proteomics Approach for Identification of Potential Drug Targets in Staphylococcus saprophyticus. |
Int. J. Environ. Res. Public Health |
3644 |
2020 |
17 |
3.39
|
|
| 90 |
TAHIR UL QAMAR M, SHAHID F, ASLAM S, ASHFAQ UA, ASLAM S, FATIMA I, FAREED MM, ZOHAIB A, CHEN LL. |
Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2 |
Infectious diseases of poverty |
1-14 |
2020 |
9 |
6.771
|
|
| 91 |
TAHIR UL QAMAR M, SHOKAT Z, MUNEER I, ASHFAQ UA, JAVED H, ANWAR F, BARI A, ZAHID B, SAARI N |
Multiepitope-based subunit vaccine design and evaluation against respiratory syncytial virus using reverse vaccinology approach |
Vaccines |
288 |
2020 |
8 |
4.961
|
|
| 92 |
IBRAHEEM F, AHMAD M, ASHFAQ UA, ASLAM S, KHAN ZA, SULTAN S |
Synthesis, molecular docking and anti-diabetic studies of novel benzimidazole-pyrazoline hybrid molecules |
Pakistan journal of pharmaceutical sciences |
847-854 |
2020 |
33 |
.863
|
|
| 93 |
KHURSHID M, RASOOL MH, ASHFAQ UA, ASLAM B, WASEEM M, ALI MA, ALMATROUDI A, RASHEED F, SAEED M, GUO Q, WANG M |
Acinetobacter baumannii Sequence Types Harboring Genes Encoding Aminoglycoside Modifying Enzymes and 16SrRNA Methylase; a Multicenter Study from Pakistan |
Infection and Drug Resistance |
2855-2862 |
2020 |
13 |
4.177
|
|
| 94 |
RASHID M, QASIM M, ISHAQ R, BUKHARI SA, SAJID Z, ASHFAQ UA, HAQUE A, AHMED ZM |
Pathogenic variants of AIPL1, MERTK, GUCY2D, and FOXE3 in Pakistani families with clinically heterogeneous eye diseases |
PloS ONE |
e0239748 |
2020 |
15 |
3.752
|
|
| 95 |
F SHAHID, UA ASHFAQ, A JAVAID, H KHALID |
Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome |
Infection, genetics and evolution |
104199 |
2020 |
80 |
4.393
|
|
| 96 |
UA ASHFAQ, H KHALID |
CRISPR/CAS9-mediated antiviral activity: A tool to combat viral infection |
Critical Reviews TM in Eukaryotic Gene Expression |
45-56 |
2020 |
30 |
2.333
|
|
| 97 |
MAZHAR SF, AFZAL M, ALMATROUDI A, MUNIR S, ASHFAQ UA, RASOOL M, RAZA H, MUNIR HM, RAJOKA MS, KHURSHID M |
The prospects for the therapeutic implications of genetically engineered probiotics |
Journal of Food Quality |
1-11 |
2020 |
2020 |
3.2
|
|
| 98 |
MUMTAZ A, ASHFAQ UA, QAMAR MT, ANWAR F, GULZAR F, AMJAD MA, SAARI N, PERVEZ MT |
MPD3: A useful medicinal plants database for drug designing |
Natural Product Research |
1051-1051 |
2020 |
34 |
2.488
|
|
| 99 |
TAHIR UL QAMAR M, REHMAN A, TUSLEEM K, ASHFAQ UA, QASIM M, ZHU X, FATIMA I, SHAHID F, CHEN LL. |
Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches |
PLoS ONE |
e0244176 |
2020 |
15 |
3.752
|
|
| 100 |
KOMAL F, KHAN MK, IMRAN M, AHMAD MH, ANWAR H, ASHFAQ UA, AHMAD N, MASROOR A, AHMAD RS, NADEEM M, NISA MU |
Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model |
Journal of Translational Medicine |
1-11 |
2020 |
8 |
7.552
|
|
| 101 |
KHALID H, LANDRY KB, IJAZ B, ASHFAQ UA, AHMED M, KANWAL A, FROEYEN M, MIRZA MU |
Discovery of novel Hepatitis C virus inhibitor targeting multiple allosteric sites of NS5B polymerase |
Infection, Genetics and Evolution |
104371 |
2020 |
84 |
4.393
|
|
| 102 |
IBRAHEEM F, AHMAD M, ASHFAQ UA*, ASLAM S, KHAN ZA, SULTAN S. |
Synthesis, molecular docking and anti-diabetic studies of novel benzimidazole-pyrazoline hybrid molecules. |
Pakistan Journal of Pharmaceutical Science, |
847-854 |
2020 |
33 |
.684
|
|
| 103 |
GHANI MU, HAQUE A, IQBAL MS, ASHFAQ UA, MAUSOOD MS, QASIM M, JAHAN S,SHAMSI FB. |
TGF-?1 rs1800469 gene polymorphism in the development of cirrhosis & hepatocellular carcinoma in Pakistani HCV patients |
Future Virology |
663-670 |
2019 |
14 |
3.015
|
|
| 104 |
IJAZ B, ASHFAQ UA, ANWAAR A, ZEESHAN, ANJUM M, HUSNAIN B |
Current Progress in HCC using CRISPR: The latest Gene Editing Tool |
The CRISPR/Cas9 System: Applications and Technology |
Chapter3 |
2019 |
1 |
0
|
|
| 105 |
AKMAL A, JAVAID A, HUSSAIN R, KAWAL A, ZUBAIR M, ASHFAQ UA*. |
Screening of phytochemicals against Keap1- NRF2 interaction to reactivate NRF2 Functioning: Pharmacoinformatics based approach. |
Pakistan Journal of Pharmacetical sciences |
2823-2828 |
2019 |
32 |
.684
|
|
| 106 |
MASROOR A, MAHR-UN-NISA, KHAN MK, ASHFAQ UA, KOMAL F. |
Inulin, Fructooligosaccharide and Lactobacillus acidophilus Affects Body Weight Gain and Blood Metabolites in Polycystic Ovarian Syndrome Rats |
International Journal Of Agriculture And Biology |
787-792 |
2019 |
4 |
.869
|
|
| 107 |
MUHAMMAD TAHIR UL QAMAR1*? , SAMAN SALEEM3?, USMAN ALI ASHFAQ3?, AMNA BARI1 , FAROOQ ANWAR4 AND SAFAR ALQAHTANI2* |
Epitope?based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study |
Journal of translational medicine |
1-14 |
2019 |
17 |
7.552
|
|
| 108 |
AHMAD, B., ASHFAQ, U.A*., RAHMAN, M.U., MASOUD, M.S. AND YOUSAF, M.Z., 2019. |
Conserved B and T cell epitopes prediction of ebola virus glycoprotein for vaccine development: an immuno-informatics approach. |
Microbial pathogenesis |
243-253 |
2019 |
132 |
3.738
|
|
| 109 |
HUSSAIN G , ASHFAQ UA, MASOUD MS, NAHID N, BHINDER MA, ASLAM N, YOUSAF N, AHMED U, QASIM M. |
Computational screening of phytochemicals against survivin protein: A potent target for cancer. |
Pakistan journal of pharmaceutical sciences |
1145-1154. |
2019 |
32 |
.863
|
|
| 110 |
KOMAL F, MAHRUN NISA, KHAN MK, ASHFAQ UA, MANZOOR F, MASROOR A, AMIR MR, UL HUDA N, KAUSAR R, NADEEM M. |
Evaluation of the efficacy of different sources of omega-3 fatty acids in polycystic ovarian syndrome (PCOS) induced rats |
Pakistan Journal of Pharmacetical sciences, |
1781-1788. |
2019 |
32 |
.684
|
|
| 111 |
TAJ S, ASHFAQ UA*, ASLAM S, AHMAD M, BHATTI SH. |
Alpha-glucosidase activity of novel pyrazolobenzothiazine 5,5-dioxide derivatives for the treatment of diabetes mellitus. Invitro combined with molecular docking approach |
Biologia |
1523-1530 |
2019 |
74 |
1.35
|
|
| 112 |
TARIQ I, FARHAN A, ASHFAQ UA, QASIM M, HUMAYUN F, SHAH M, MUNIR A. MASOUD MS |
Study on structural insight of the analysis of negative effects of opioids analgesics in naltrexone with TLR4 Mutations |
Pakistan Journal of pharmaceutical sciences |
345-351 |
2019 |
32 |
.863
|
|
| 113 |
RASUL I, ZAFAR F, ALI MA, NADEEM H, SIDDIQUE MH, SHAHID M, ASHFAQ UA, AZEEM F. |
Genetic Basis for Biotic Stress Resistance in Plants from Solanaceae Family: A Review. |
International Journal of Agriculture And Biology. |
178-194 |
2019 |
22 |
.869
|
|
| 114 |
TAHIR UL QAMAR M, MARYAM A, MUNEER I, XING F, ASHFAQ UA, KHAN FA, ANWAR F, GEESI MH, KHALID RR, RAUF SA, SIDDIQI AR |
Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus |
Scientific reports |
1-16 |
2019 |
9 |
5.516
|
|
| 115 |
A AKMAL, A JAVAID, R HUSSAIN, A KANWAL, M ZUBAIR, UA ASHFAQ |
Screening of phytochemicals against KEAP1-NRF2 interaction to reactivate NRF2 Functioning: Pharmacoinformatics based approach |
Pakistan Journal of Pharmaceutical Sciences |
2823-2828 |
2019 |
32 |
.863
|
|
| 116 |
MASOUD MS, AHMAD U, QASIM M, ASHFAQ UA, RAHMAN M AND TARIQ M |
Mesenchymal Stem Cells in the Regeneration to Damaged Myocardium: Modern Research Trends and Clinical Prospects |
Advances in Medicine and Biology, Nova Science Publisher |
Chapter 5 |
2019 |
136 |
0
|
|
| 117 |
SADDIQUE FA, AHMAD M, ASHFAQ UA*, AHMAD MN, ANJUM MN, MOHSIN NM, ASLAM S. |
Alpha-glucosidase inhibition and molecular docking studies of 1,2- benzothiazine 1,1-dioxide based carbohydrazides |
Pakistan Journal of Pharmaceutical Sciences |
p2829-2834. 6p |
2019 |
32 |
.863
|
|
| 118 |
AHMED B, ASHFAQ UA, MIRZA MU |
Medicinal plant phytochemicals and their inhibitory activities against pancreatic lipase: molecular docking combined with molecular dynamics simulation approach |
Natural product research |
1123-1129 |
2018 |
32 |
2.488
|
|
| 119 |
UL QAMAR MT, BARI A, ADEEL MM, MARYAM A, ASHFAQ UA, DU X, MUNEER I, AHMED HI, WANG J |
Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approach |
Journal of translational medicine |
298 |
2018 |
16 |
7.552
|
|
| 120 |
IQBAL MS, ASHFAQ UA, ASLAM S, KHALIQ S, GHANI MU, BATOOL F |
Analysis of polymorphism rs1990760 of IFIH1 gene and treatment outcomes in HCV infection |
Future virology |
181-187 |
2018 |
13 |
3.015
|
|
| 121 |
MASOUD MS, ASHFAQ UA KHALID S, |
Interferon-Free Regimen for Hepatitis C: Insight and Management. |
Critical Review in Eukaryotic Gene Expression |
373-384 |
2018 |
28 |
1.734
|
|
| 122 |
YOUSAF MZ, ASHFAQ UA, ANJUM KM, FATIMA S |
Crimean-Congo Hemorrhagic Fever (CCHF) in Pakistan: The bell is Ringing Silently |
Critical Review in Eukaryotic Gene expression |
93-100 |
2018 |
28 |
1.734
|
|
| 123 |
YOUSAF MZ, SIDDIQUE A, ASHFAQ UA, ALI M |
Scenario of dengue infection & its control in Pakistan: An update and way forward |
Asian Pacific Journal of Tropical Medicine |
15 |
2018 |
11 |
3.041
|
|
| 124 |
YOUSAF M, JUNAID K, IQBAL MS, ASLAM I, AHMAD S, AQEEL M, ASHFAQ UA, KHALIQ S, GHANI MU, WAQAR N |
Analysis of dengue virus burden and serotypes pattern in Faisalabad, 2016?2017 |
Future Virology |
245-251 |
2018 |
13 |
3.015
|
|
| 125 |
REHMAN S, ASHFAQ UA, IJAZ B, JABEEN Z, RIAZUDDIN S |
Comparison of Anti-HCV Activity of Multiple Punica granatum Extracts and Fractions in Virus-infected Human Hepatocytes |
Current pharmaceutical biotechnology |
1221-1231 |
2018 |
19 |
1.819
|
|
| 126 |
REHMAN S, ASHFAQ UA, IJAZ B, RIAZUDDIN S |
Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells |
Microbial Pathogenesis |
198-209 |
2018 |
121 |
2.332
|
|
| 127 |
4. ASLAM N, BATOOL F, IQBAL MS, ASHFAQ UA, AYAZ S, KHALIQ S, JAHAN S, GHANI MS, USMAN M |
Analysis of toll-like receptors-9 (TLR9) gene polymorphism (rs5743836) in Pakistani patients with HCV |
Pakistan journal of pharmaceutical sciences |
2709-2714 |
2018 |
31 |
.863
|
|
| 128 |
MZ YOUSAF, S ZIA, KM ANJUM, UA ASHFAQ, M IMRAN, S AFZAL, MS IQBAL |
Deadly outbreak of chickenpox at district Faisalabad, Pakistan: possible causes, and preventive way forward |
Molecular biology reports |
2941-2943 |
2018 |
45 |
2.702
|
|
| 129 |
AVAID MS, LATIEF N, IJAZ B, ASHFAQ UA |
Epigallocatechin Gallate as an anti-obesity therapeutic compound: an in silico approach for structure-based drug designing |
Natural Product Research |
2121-2125 |
2018 |
32 |
2.488
|
|
| 130 |
S FIRASAT, H KAUL, UA ASHFAQ, S IDREES |
In silico analysis of five missense mutations in CYP1B1 gene in Pakistani families affected with primary congenital glaucoma |
International ophthalmology |
807-814 |
2018 |
38 |
1.99
|
|
| 131 |
DURDAGI S, UL QAMAR MT, SALMAS RE, TARIQ Q, ANWAR F. ASHFAQ UA |
Investigating the molecular mechanism of staphylococcal DNA gyrase inhibitors: A combined ligand-based and structure-based resources pipeline |
Journal of Molecular Graphics and Modeling |
122-129 |
2018 |
85 |
1.885
|
|
| 132 |
UL QAMAR MT, ASHFAQ UA, TUSLEEM K, MUMTAZ A TARIQ Q, GOHEER A, AHMED B |
In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach. |
Pakistan journal of pharmaceutical sciences |
2119-2137 |
2017 |
30 |
.863
|
|
| 133 |
ASHFAQ UA, RIAZ M,YASMEEN E, YOUSAF MZ |
Recent Advances in Nanoparticles Based Targeted Drug Delivery Systems Against Cancer and Role of Tumor Microenvironment |
Critical Reviews TM in Therapeutic Drug Carrier Systems |
317-353 |
2017 |
34 |
4.681
|
|
| 134 |
ASHFAQ UA, KHALID H |
Mechanism of Hepatitis C Virus???Induced Diabetes Mellitus |
Critical Review in Eukaryotic Gene Expression |
363-371 |
2017 |
27 |
1.559
|
|
| 135 |
RIAZ M, ASHFAQ UA, QASIM M, YASMEEN E, UL QAMAR MT.; ANWAR F. |
Screening of medicinal plant phytochemicals as natural antagonists of p53-MDM2 interaction to reactivate p53 functioning |
Anticancer drugs |
1032-1038 |
2017 |
28 |
2.389
|
|
| 136 |
ARSHAD A, ASHFAQ UA |
Epidemiology of Hepatitis C infection in Pakistan: Current estimate and major risk factors |
Critical Review in Eukaryotic Gene Expression |
63-67 |
2017 |
27 |
559
|
|
| 137 |
ASHFAQ UA, RIAZ M, YASMEEN E, QASIM M, MASOUD MS |
Computer aided drug designing: A safari to drug formulation |
Advances in medicine and Biology, Nova Biomedical Publishers |
155-174 |
2017 |
115 |
0
|
|
| 138 |
IQBAL MS, ASHFAQ UA, KHALIQ S, MASOUD MS, QASIM M,USMAN G, HAQUE A, JAHAN S |
TLR4 polymorphism as pretreatment predictor of response to HCV genotype 3a IFN-based treatment |
Future Virology |
739-746 |
2017 |
12 |
3.015
|
|
| 139 |
M QSIM, UA ASHFAQ, MZ YOUSAF, MS MASOUD, I RASUL, N NOOR, A HUSSAIN |
Genetically Modified Aedes aegypti to Control Dengue: A Review |
Critical Reviews? in Eukaryotic Gene Expression |
331-340 |
2017 |
27 |
2.333
|
|
| 140 |
M KHURSHID, MH RASOOL, UA ASHFAQ, B ASLAM, M WASEEM |
Emergence of ISAba1 harboring carbapenem-resistant Acinetobacter baumannii isolates in Pakistan |
Future microbiology |
1261-1269 |
2017 |
12 |
3.553
|
|
| 141 |
IQBAL MS, ASHFAQ UA, KHALIQ S, MASOUD MS, QASIM M, HAQUE A, GHANI MU, JAHAN S |
Toll-like receptor 4 polymorphism as pretreatment predictor of response to HCV genotype 3a interferon-based treatment |
Future Virology |
739-746 |
2017 |
12 |
3.015
|
|
| 142 |
JAVIAD MS, ASHFAQ UA, MASOUD MS |
Potential of stem cells as regenerative medicine: From preface to advancements |
Critical Review in Eukaryotic Gene Expression |
1-17 |
2017 |
27 |
2.333
|
|
| 143 |
ASHFAQ UA, AHMED B |
De novo Structural Modeling and Conserved Epitopes Prediction of Zika Virus Envelop Protein for Vaccine Development |
Viral Immunology |
436-443 |
2016 |
29 |
2.175
|
|
| 144 |
KAUL H, SUMAN M, KHAN Z, ULLAH MI, ASHFAQ UA, IDREES S |
Missense mutation in SLC4A11 in two Pakistani families affected with congenital hereditary endothelial dystrophy (CHED2) |
Clinical and Experimental Optometry |
73-77 |
2016 |
99 |
1.28
|
|
| 145 |
UL QAMAR MT, KIRAN S, ASHFAQ UA, JAVED MR,ANWAR F, ALI MA, GILANI AH |
Discovery of Novel Dengue NS2B/NS3 Protease Inhibitors Using Pharmacophore Modeling and Molecular Docking Based Virtual Screening of the ZINC Database |
International Journal of Pharmacology |
621-632 |
2016 |
12 |
.536
|
|
| 146 |
SAJID Z, AHMAD, M, ASLAM S, ASHFAQ UA, ZAHOOR AF,SADDIQUE FA,PARVEZ M,HAMEED A, SULTAN S, ZGOU H, HADDATB |
Novel Armed Pyrazolobenzothiazine Derivatives: Synthesis, X-Ray Crystal Structure and POM analyses of Biological Activity Against Drug Resistant Clinical Isolate of Staphylococcus aureus |
Pharmaceutical Chemistry Journal |
172-180 |
2016 |
50 |
.461
|
|
| 147 |
ASHFAQ UA, IQBAL MS, KHALIQ S |
Role of Toll-Like Receptors in Hepatitis C Virus Pathogenesis and Treatment |
Critical Reviews TM in Eukaryotic Gene Expression |
353-362 |
2016 |
26 |
2.333
|
|
| 148 |
ASHFAQ UA, JALIL A, UL QAMAR MT |
Antiviral phytochemicals identification from Azadirachta indica leaves against HCV NS3 protease: an in silico approach |
Natural Product Research |
1866-1869 |
2016 |
30 |
2.488
|
|
| 149 |
AHMAD M, ASLAM S, RIZVI SUF, MUDDASSAR M, ASHFAQ UA, MONTERO C, OLLINGER O, DETORIO,M, GARDINER JM, SCHINAZ FR |
Molecular docking and antiviral activity of N-substituted benzyl/phenyl-2-(3,4-dimethyl-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-2(4H)-yl)acetamides |
Bioorganic & Medicinal Chemistry Letters |
1348-1351 |
2015 |
25 |
2.42
|
|
| 150 |
RAJOKA MI, IDREES S, ASHFAQ UA, HAQUE A |
Determination of Substrate Specificities Against beta-Glucosidase A (BglA) from Thermotoga maritime: A Molecular Docking Approach |
Journal of microbiology and Biotechnology |
44-49 |
2015 |
25 |
1.525
|
|
| 151 |
S IDREES, UA ASHFAQ, MS MASOUD, M QASIM, T JAVED, A ALI |
Gene expression profiling of immune responsive and fibrosis genes in hepatitis C virus infected patients |
Viral Immunology |
250-254 |
2015 |
27 |
2.175
|
|
| 152 |
NOREEN S, HUSSAIN I, TARIQ MI, IJAZ B, IQBAL S, QAMAR-UL-ZAMAN, ASHFAQ UA, HUSNAIN T |
Portulaca oleracea L. as a Prospective Candidate Inhibitor of Hepatitis C Virus NS3 Serine Protease |
Viral Immunology |
282-289 |
2015 |
28 |
2.175
|
|
| 153 |
BUKHARI M, ASLAM MA, KHAN A, IRAM Q, AKBAR A, NAZ AG, AHMAD S, AHMAD MM, ASHFAQ UA, AZIZ H, ALI M |
TLR 8 gene polymorphism and association in bacterial load in southern P unjab of P akistan: an association study with pulmonary tuberculosis |
International journal of immunogenetics |
46-51 |
2015 |
42 |
2.385
|
|
| 154 |
M BUKHARI, MA ASLAM, A KHAN, Q IRAM, A AKBAR, AG NAZ, S AHMAD, MM AHMAD, UA ASHFAQ, H AZIZ, M ALI |
TLR8 gene polymorphism and association in bacterial load in southern Punjab of Pakistan: an association study with pulmonary tuberculosis |
Interna tional Journal of Immunogenetic s |
46-51 |
2015 |
42 |
1.247
|
|
| 155 |
USMAN ALI ASHFAQ, SOBIA IDREES |
RNA Interference as a Therapeutic Strategy Against Viral Diseases |
Diseases and Theranostics |
Chapter17 |
2014 |
9 |
0
|
|
| 156 |
ASLAM S, AHMAD M, ATHAR MM, ASHFAQ UA, GARDINER JM, MONTERO C, DETORIO M, PARVEZ M, SCHINAZI RF |
Synthesis, molecular docking and antiviral screening of novel N0 -substitutedbenzylidene-2-(4-methyl-5,5-dioxido-3- phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-1(4H)-yl) acetohydrazides |
Medicinal Chemistry Research |
2930-2946 |
2014 |
23 |
2.261
|
|
| 157 |
UA ASHFAQ, S IDREES |
Medicinal plants against hepatitis C virus |
World journal of gastroenterology |
2941 |
2014 |
20 |
5.374
|
|
| 158 |
MT UL QAMAR, A MUMTAZ, UA ASHFAQ, MM ADEEL, T FATIMA |
Potential of plant alkaloids as dengue ns3 protease inhibitors: Molecular docking and simulation approach |
Bangladesh Journal of Pharmacology |
262-267 |
2014 |
9 |
1.143
|
|
| 159 |
S IDREES, UA ASHFAQ |
Journey of Protein from Sequence to Structure: An Innovative Bioinformatics Approach |
Biotechnology Vol. 6: Bioinformatics and Computational Biology |
Chapter7 |
2014 |
6 |
0
|
|
| 160 |
B AHMED, UA ASHFAQ, MT UL QAMAR, M AHMAD |
Anti-cancer potential of phytochemicals against breast cancer: Molecular docking and simulation approach |
Bangladesh Journal of Pharmacology |
545-50 |
2014 |
9 |
1.143
|
|
| 161 |
S IDREES, UA ASHFAQ |
Structural analysis and epitope prediction of HCV E1 protein isolated in Pakistan: an in-silico approach |
Virology Journal |
1-8 |
2013 |
10 |
4.372
|
|
| 162 |
S IDREES, UA ASHFAQ, S KHALIQ |
HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development |
Journal of Translational Medicine |
1-9 |
2013 |
11 |
7.552
|
|
| 163 |
AYUB A, ASHFAQ UA, HAQUE |
HBV induced HCC: major risk factors from genetic to molecular level |
Biomed Research International |
810461 |
2013 |
2013 |
3.246
|
|
| 164 |
JAVAID A, ZAHRA D, RASHID F, MASHRAQI M, ALZAMAMI A, KHURSHID M, ASHFAQ UA |
Regulation of micro-RNA, epigenetic factor by natural products for the treatment of cancers: Mechanistic insight and translational association |
Saudi Journal of Biological Sciences |
103255 |
2013 |
29 |
4.052
|
|
| 165 |
S IDREES, UA ASHFAQ, M ZAHOOR, S RAMZAN |
Molecular modeling and interaction studies of HCV core protein |
Virology & Mycology |
2161-0517.1000 |
2013 |
2 |
2.45
|
|
| 166 |
S JAHAN, UA ASHFAQ, S KHALIQ, B SAMREEN, N AFZAL |
Dual behavior of HCV Core gene in regulation of apoptosis is important in progression of HCC |
Infection, Genetics and Evolution |
236-239 |
2012 |
12 |
4.393
|
|
| 167 |
SAMREEN B, KHALIQ S, ASHFAQ UA, KHAN M, AFZAL N, SHAHZAD MA, RIAZ S, JAHAN S |
Hepatitis C virus entry: role of host and viral factors |
Infection, Genetics and Evolution |
1699-709 |
2012 |
12 |
4.393
|
|
| 168 |
S JAHAN, UA ASHFAQ, M QASIM, S KHALIQ, MJ SALEEM, N AFZAL |
Hepatitis C virus to hepatocellular carcinoma |
Infectious Agents and Cancer |
1-8 |
2012 |
7 |
3.572
|
|
| 169 |
MZ YOUSAF, M QASIM, S ZIA, M REHMAN KHAN, UA ASHFAQ, S KHAN |
Rabies molecular virology, diagnosis, prevention and treatment |
Virology journal |
1-5 |
2012 |
9 |
4.372
|
|
| 170 |
T JAVED, UA ASHFAQ, S RIAZ, S REHMAN, S RIAZUDDIN |
In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus |
Virology Journal |
1-7 |
2011 |
8 |
4.372
|
|
| 171 |
U ALI ASHFAQ, M ANSAR, MT SARWAR, T JAVED, S REHMAN, S RIAZUDDIN |
Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA |
Virology journal |
1-5 |
2011 |
8 |
4.372
|
|
| 172 |
S KHALIQ, S JAHAN, A PERVAIZ, U ALI ASHFAQ, S HASSAN |
Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs |
Virology Journal |
1-9 |
2011 |
8 |
4.372
|
|
| 173 |
JAHAN S, KHALIQ S, SAMREEN B, IJAZ B, KHAN M, AHMAD W, ASHFAQ UA, HASSAN S |
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV |
Virology Journal |
1-6 |
2011 |
8 |
4.372
|
|
| 174 |
UA ASHFAQ, MZ YOUSAF, M ASLAM, R EJAZ, S JAHAN, O ULLAH |
siRNAs: potential therapeutic agents against hepatitis C virus |
Virology Journal |
1-6 |
2011 |
8 |
4.372
|
|
| 175 |
UA ASHFAQ, T JAVED, S REHMAN, Z NAWAZ, S RIAZUDDIN |
An overview of HCV molecular biology, replication and immune responses |
Virology Journal |
1 - 10 |
2011 |
8 |
4.372
|
|
| 176 |
UA ASHFAQ, T JAVED, S REHMAN, Z NAWAZ, S RIAZUDDIN |
Inhibition of HCV 3a core gene through Silymarin and its fractions |
Virology Journal |
1-7 |
2011 |
8 |
4.372
|
|
| 177 |
UA ASHFAQ, T JAVED, S REHMAN, Z NAWAZ, S RIAZUDDIN |
Lysosomotropic agents as HCV entry inhibitors |
Virology Journal |
1-6 |
2011 |
8 |
4.372
|
|
| 178 |
SARWAR MT, KAUSAR H, IJAZ B, AHMAD W, ANSAR M, SUMRIN A, ASHFAQ UA, ASAD S, GULL S, SHAHID I, HASSAN S |
NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b |
Virology journal |
1-19 |
2011 |
8 |
4.372
|
|
| 179 |
S REHMAN, UA ASHFAQ, S RIAZ, T JAVED, S RIAZUDDIN |
Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells |
Virology journal |
1-6 |
2011 |
8 |
4.372
|
|
| 180 |
S JAHAN, S KHALIQ, MH SIDDIQI, B IJAZ, W AHMAD, UA ASHFAQ, S HASSAN |
Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line |
Virology Journal |
1-7 |
2011 |
8 |
4.372
|
|
| 181 |
MZ YOUSAF, S ZIA, ME BABAR, UA ASHFAQ |
The epidemic of HIV/AIDS in developing countries; the current scenario in Pakistan |
Virology Journal |
1-7 |
2011 |
8 |
4.372
|
|
| 182 |
UA ASHFAQ, MS MASOUD, Z NAWAZ, S RIAZUDDIN |
Glycyrrhizin as antiviral agent against Hepatitis C Virus |
Journal of translational medicine |
1-7 |
2011 |
9 |
7.552
|
|
| 183 |
ANSAR M, ASHFAQ UA, SHAHID I, SARWAR MT, JAVED T, REHMAN S, HASSAN S, RIAZUDDIN S |
Inhibition of full length hepatitis C virus particles of 1a genotype through small interference RNA |
Virology Journal |
1-6 |
2011 |
8 |
4.372
|
|
| 184 |
UA ASHFAQ, M QASIM, MZ YOUSAF, MT AWAN, S JAHAN |
Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies |
Journal of Translational Medicine |
1-6 |
2011 |
9 |
7.552
|
|
| 185 |
UA ASHFAQ, S KHALIQ, S JAHAN |
RNAi to Treat Chronic Hepatitis C Infection |
Wiley Online Library |
1-30 |
2006 |
1 |
0
|
|